Reading a Peptide HPLC Trace — A 5-Minute Field Guide

If you've never had to defend a peptide lot to a paper reviewer or a CRO QA team, the HPLC chromatogram on the lot report can look like a wall of squiggles with one obvious tall peak. This Note walks through what those squiggles actually mean — at the level of detail a working bench scientist needs to read the document at receipt, in five minutes, without leaving the bench.

What you are looking at

Every Lyochem lot ships with a reversed-phase HPLC (RP-HPLC) trace — a plot of detector signal (typically UV absorbance at 214 nm, the peptide-bond wavelength, or 280 nm for tyrosine/tryptophan-rich sequences) versus time. The peptide is pumped through a C18 column under a gradient of increasing acetonitrile in water, both with 0.05–0.1% trifluoroacetic acid (TFA) as the ion-pair modifier. Each component in the mixture elutes at a characteristic time (the retention time, tR), set by its hydrophobicity, charge state, and any conformation differences from the labelled peptide.

The chromatogram you receive is the proof that we resolved the synthesised peptide from its impurities — not just that we measured a mass that matches.

Anatomy of a clean lot

A well-purified ≥99% peptide trace has four visible features:

• A flat early baseline from t = 0 until just before the main peak. This is the column running water + a little acetonitrile, with nothing eluting yet. A noisy, rising, or peaked baseline here usually means residual TFA or solvent-system carryover — not a peptide impurity.
• A small cluster of minor peaks in the 1.5–5 minute window. These are typically the truncations of the synthesis — peptide chains that lost one or two residues during solid-phase synthesis. For a ≥98.5% lot, each of these is below the integration threshold (often <0.1% of total peak area). Their existence is expected and is not a quality issue; their *size* is.
• The main peak at the expected retention time for the synthesised sequence. For BPC-157 on a standard gradient this is around 6.8 minutes; for TB-500 around 8–9 minutes; for cyclic peptides like oxytocin shifted earlier than the linear reduced form by roughly half a minute. The integration value next to this peak is your purity number — the percentage of the total absorbance under the chromatogram that belongs to this peak.
• A clean tail after the main peak. Late-eluting impurities (aggregates, more hydrophobic by-products) elute here. For a well-purified lot, this region should be visually indistinguishable from the early baseline.

What the numbers next to the peaks mean

The lot report lists each integrated peak with:

• Retention time (tR) in minutes — where on the time axis the peak's apex sits. Reproducibility of tR across lots is itself a quality signal: a well-controlled column, gradient, and method should give the main peak at the same tR (±0.1 min) every release.
• Area under the curve (AUC) in arbitrary detector units. Useful for the supplier; not directly meaningful to you.
• Relative area (%) — the integrated AUC of that peak divided by the total AUC of all integrated peaks. This is the purity number you cite when you say "≥99% by HPLC".

A note on what the purity number is *not*: it is not absolute mass-balance purity. UV absorbance scales with chromophore content per molecule, so an impurity that absorbs less than the main peptide at 214 nm (e.g. a truncation missing tryptophan) will read as smaller than its mass fraction. For mass-balance purity, the lot report carries a separate amino-acid analysis (AAA) number; for most research workflows the HPLC purity is the right reading.

Three things to check at receipt

1. Is the main-peak purity at or above the spec on the CoA cover page? This is the only number that constitutes a release decision. If the document says 98.74% and the spec is ≥98.5%, the lot is releasable.
2. Is the main-peak retention time consistent with the published method and previous lots? A ±0.1 min drift is normal column behaviour; a ±0.5 min drift wants a conversation with the supplier (column ageing, gradient drift, or method change).
3. Are the minor peaks within the same envelope as previous lots? A new shoulder at a previously-empty time slot is not necessarily a problem, but it is worth flagging — it can indicate a synthesis or purification change worth understanding before scale-up work commits to the lot.

When HPLC alone is not enough

HPLC purity by area tells you that the labelled peak is a high fraction of what came off the column. It does NOT tell you that the peak is the labelled sequence. For first-time supplier qualification of any peptide, request the LC-MS/MS sequence-ladder data alongside the HPLC trace; that directly demonstrates that the synthesised molecule matches the labelled sequence rather than only matches a matching mass. (Mass spec alone can be deceived by isomers, scrambled cyclisations, and same-mass truncation-plus-elongation by-products; the b/y-ion ladder cannot.)

The shorthand

If you only have ninety seconds at the bench:

• Glance at the cover-page purity number — must be at or above spec.
• Glance at the chromatogram main-peak tR — should look like every other lot.
• Glance at the early baseline and the late tail — should both look flat.

If those three are right, the lot is releasable into a research workflow. If any of the three look off, send the trace plus the lot reference to your atelier contact and ask the question; per-lot data exists so that conversation can be specific.